After this article [1] was published, concerns were raised with Fig 7, S1 Fig and S4 Fig in S1 File. Specifically:

• In Fig 7B, the Mock VE-cadherin panel appears to overlap with the Fig 7B ZIKV FA-S VE-cadherin panel.
• In Fig 7B, the Mock CellTracker panel appears to overlap with the Fig 7B ZIKV FA-S CellTracker panel.
• In S1E Fig in S1 File, beta-actin (lanes 2–5) appears similar to S4H Fig in S1 File beta-actin (lanes 1–4).

Corresponding author YLL stated that the confocal immunofluorescence images for the Mock group of C57BL/6 mice in Fig 7B are incorrect. A correct version of Fig 7 is provided here where the three Mock panels in Fig 7B have been replaced with the correct panels from the original experiments, and the white rectangles in the CellTracker FA-S and FA-H panels in Fig 7B have been moved. The underlying data for Fig 7 is provided in S1 File.

Corresponding author YLL provided the underlying blots for S1 Fig and S4 Fig in S1 File. The PLOS Pathogens Editors therefore consider this concern resolved.

The raw data underlying Figs 1-5, S1-S3 Figs in S1 File and S5-S7 Figs in S2 File are missing from the list of Supporting Information. The authors have provided the data as Supporting Information S1-S2 Files. With this correction, all relevant data are now provided.

Download:

• PNG
  larger image
• TIFF
  original image

Fig 7. FA improves the prognostic profile of placental dysfunction.

(A-B) Representative confocal images of placental sections of AGB6 mice (A) and IFNAR1 antibody-treated C57BL/6 (B) Placenta immunostained for VE-cadherin (red) and CellTracker for cytoplasm (green). (C-D) Western blot analysis of protein level of VE-cadherin, HIF-1α, cleaved caspase-3, and β-actin for loading control of placental AGB6 (C) and IFNAR1 antibody-treated C57BL/6 (D) mice. Samples are pooled placental tissue lysates of 3–4 representative pregnant mice (d1-d4).

https://doi.org/10.1371/journal.ppat.1014363.g007